All News
|
News Release
The U.S. Food and Drug Administration approved two new gene therapies to treat sickle cell disease — one a gene-editing and the other a gene-addition approach. Nearly 100,000 people in the United States — and millions worldwide — have been diagnosed with this painful, life-threatening genetic blood disease. To help explain the historic importance...
Showing 8 out of 2148 results
Research Feature
The $63 million NHLBI Large-Scale DNA Sequencing Project is a "Grand Opportunity" Recovery Act project that will find genetic signatures for heart, lung, and blood diseases that account for 3 of the 4 leading causes of death in the United States. President Barack Obama announced the award September 30, 2009, as part of the $5 billion in new...
NHLBI in the Press
Researchers are reporting a new way of analyzing genetic test data that may help identify people at high risk of heart disease and other common medical conditions.
Research Feature
Research Feature
National Institutes of Health- (NIH) supported research is shedding light on how sleep and lack of sleep affect the human body. The NIH and its partners will continue to work together to advance sleep research. Download an accessible PDF version of the infographic .